European Radiology

, Volume 16, Issue 10, pp 2234–2241 | Cite as

Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results

  • Tommaso Vincenzo Bartolotta
  • Massimo Midiri
  • Massimo Galia
  • Giuseppe Runza
  • Marco Attard
  • Giovanni Savoia
  • Roberto Lagalla
  • Adelfio Elio Cardinale
Head and Neck


To assess the feasibility of contrast-enhanced ultrasound (CEUS) of the thyroid gland and to evaluate the potential of this method for characterising solitary thyroid nodules.18 patients affected by solitary thyroid nodules (size range: 0.6 to 3.6 cm; mean: 1.8 cm) confirmed by surgery (nine papillary carcinomas, four follicular carcinomas, three hyperplasias, one follicular adenoma and one Plummer’s adenoma) underwent pulse inversion US at low M.I. (0.06 to 0.08) after i.v. injection of a 2.4-mL bolus of SonoVue. Baseline echogenicity and the dynamic enhancement pattern of each nodule, in comparison with adjacent thyroid parenchyma, were assessed. Signal intensity values on grey-scale images were also calculated at baseline, 30 s, 60 s and 120 s after SonoVue administration. Following administration of SonoVue, malignant nodules showed absent (4 out of 13), faint dotted (4 out of 13) and diffuse (5 out of 13) contrast enhancement, in this last case inhomogeneous (4 out of 5 cases) or homogeneous (1 out of 5). Benign nodules showed diffuse contrast enhancement, both homogeneous (3 out of 5) and heterogeneous (2 out of 5). Quantitative data have confirmed subjective findings, but CEUS never modified precontrast analysis. CEUS of thyroid gland is a feasible technique, but overlapping findings seem to limit the potential of this technique in the characterization of thyroid nodules.


Thyroid Ultrasound Contrast agent 


  1. 1.
    Solbiati L, Osti V, Cova L, Tonolini M (2001) Ultrasound of thyroid, parathyroid glands and neck limph nodes. Eur Radiol 11:2411–2424PubMedCrossRefGoogle Scholar
  2. 2.
    Brander A, Viikinkoski P, Nickels J, Kivisaari L (1991) Thyroid gland: US screening in a random adult population. Radiology 181:683–687PubMedGoogle Scholar
  3. 3.
    Ezzat S, Sarti DA, Cain DR, Braunstein GD (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838–1840PubMedCrossRefGoogle Scholar
  4. 4.
    Wiest PW, Hartshorne MF, Inskip PD, Crooks LA, Vela BS, Telepak RJ, Williamson MR, Blumhardt R, Bauman JM, Tekkel M (1998) Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 17:487–496PubMedGoogle Scholar
  5. 5.
    Tan GH, Gharib H, Reading CC (1995) Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med 155:2418–2423PubMedCrossRefGoogle Scholar
  6. 6.
    Ross DS (2002) Nonpalpable thyroid nodules-managing an epidemic. J Clin Endocrinol Metab 87:1938–1940PubMedCrossRefGoogle Scholar
  7. 7.
    Wang C, Crapo LM (1997) The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189–218PubMedCrossRefGoogle Scholar
  8. 8.
    Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C (1993) Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 71:4022–4029PubMedCrossRefGoogle Scholar
  9. 9.
    Burns PN, Wilson SR, Simpson DH (2000) Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 35:58–71PubMedCrossRefGoogle Scholar
  10. 10.
    Argalia G, De Bernardis S, Mariani D et al (2002) Ultrasonographic contrast agent: evaluation of time intensity curves in the characterisation of solitary thyroid nodules. Radiol Med 103:407–413PubMedGoogle Scholar
  11. 11.
    Spiezia S, Farina R, Cerbone G et al (2001) Analysis of color Doppler signal intensity variation after levovist injection: a new approach to the diagnosis of thyroid nodules. J Ultrasound Med 20:223–231PubMedGoogle Scholar
  12. 12.
    Schneider M, Arditi M, Barrau M et al (1995) BRI: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbes. Invest Radiol 30:451–457PubMedCrossRefGoogle Scholar
  13. 13.
    Quaia E, Calliada F, Bertolotto M et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420–430PubMedCrossRefGoogle Scholar
  14. 14.
    Bartolotta TV, Midiri M, Quaia E et al (2005) Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US. Eur Radiol 15:685–693PubMedCrossRefGoogle Scholar
  15. 15.
    Bartolotta TV, Midiri M, Quaia E et al (2005) Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography. Eur Radiol 15:1643–1649PubMedCrossRefGoogle Scholar
  16. 16.
    World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Available at: Accessed 1 September 2003
  17. 17.
    Leen E, Angerson WJ, Yarmenitis S et al (2002) Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 41:200–206PubMedCrossRefGoogle Scholar
  18. 18.
    Solbiati L, Livraghi T, Ballarati E, Ierace T, Crespi L (1996) Thyroid gland. In: Solbiati L, Rizzatto G, Charboneau JW (eds) Ultrasound of superficial structures. Churchill-Livingstone, Edinburgh, pp 48–85Google Scholar
  19. 19.
    Kim EK, Park CS, Chung WY et al (2002) New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol 178:687–691Google Scholar
  20. 20.
    Lagalla R, Caruso G, Novara V, Cardinale AE (1993) Flowmetric analysis of thyroid diseases: hypothesis on integration with qualitative color-Doppler study. Radiol Med 85:606–610PubMedGoogle Scholar
  21. 21.
    Papini E, Guglielmi R, Bianchini A et al (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941–1946PubMedCrossRefGoogle Scholar
  22. 22.
    Bertolotto M, Dalla Palma L, Quaia E, Locatelli M (2000) Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 10:1369–1376PubMedCrossRefGoogle Scholar
  23. 23.
    Bartolotta TV, Midiri M, Scialpi M, Sciarrino E, Galia M, Lagalla R (2004) Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound. Eur Radiol 14:583–591PubMedCrossRefGoogle Scholar
  24. 24.
    Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M (1994) Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg 18:495–498PubMedCrossRefGoogle Scholar
  25. 25.
    Marqusee E, Benson CB, Frates MC et al (2000) Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696–700PubMedGoogle Scholar
  26. 26.
    Gritzmann N, Koischwitz D, Rettenbacher T (2000) Sonography of the thyroid and parathyroid glands. Radiol Clin North Am 38:1131–1145PubMedCrossRefGoogle Scholar
  27. 27.
    Solbiati L (1998) Thyroid gland. In: James EM (ed) Diagnostic ultrasound. Mosby, St Louis, pp 703–729Google Scholar
  28. 28.
    Kats JF, Kane RA, Reyes J, Clarke MP, Hill TC (1984) Thyroid nodules: sonographic-pathologic correlation. Radiology 151:741–745Google Scholar
  29. 29.
    Rago T, Vitti P, Chiovato L et al (1998) Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in ‘cold’ thyroid nodules. Eur J Endocrinol 138:41–46PubMedCrossRefGoogle Scholar
  30. 30.
    Hagag P, Strauss S, Weiss M (1988) Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 8:989–995CrossRefGoogle Scholar
  31. 31.
    Schneider M (1999) SonoVue, a new ultrasound contrast agent. Eur Radiol 9(Suppl.3):S347–S348PubMedCrossRefGoogle Scholar
  32. 32.
    Leen E (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(Suppl. 3):E27–E34PubMedCrossRefGoogle Scholar
  33. 33.
    Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 12:151–165PubMedCrossRefGoogle Scholar
  34. 34.
    Solbiati L, Tonolini M, Cova L, Goldberg N (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11(Suppl. 3):E15–E26PubMedCrossRefGoogle Scholar
  35. 35.
    Albrecht T, Oldenburg A, Hohmann J et al (2003) Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur Radiol 13(Suppl 3):79–86CrossRefGoogle Scholar
  36. 36.
    Passe TJ, Bluemke DA, Siegelman SS (1997) Tumor angiogenesis: tutorial on implications for imaging. Radiology 203:593–600PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Tommaso Vincenzo Bartolotta
    • 1
    • 3
  • Massimo Midiri
    • 1
  • Massimo Galia
    • 1
  • Giuseppe Runza
    • 1
  • Marco Attard
    • 2
  • Giovanni Savoia
    • 2
  • Roberto Lagalla
    • 1
  • Adelfio Elio Cardinale
    • 1
  1. 1.Department of RadiologyUniversity of PalermoPalermoItaly
  2. 2.Department of EndocrinologyVincenzo Cervello HospitalPalermoItaly
  3. 3.PalermoItaly

Personalised recommendations